Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01006889
What this trial is testing

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 24
Not applicableStudy completedNCT03375008
What this trial is testing

Predictable MR Index for Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Korea University Guro Hospital 47
Not applicableUnknownNCT03842748
What this trial is testing

Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis

Who this might be right for
Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals 300
Testing effectiveness (Phase 2)Looking for participantsNCT07527910
What this trial is testing

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 204
Not applicableActive Not RecruitingNCT06503120
What this trial is testing

Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Fatty Liver, NonalcoholicDiet, Healthy
Taichung Veterans General Hospital 78
Testing effectiveness (Phase 2)Looking for participantsNCT04501406
What this trial is testing

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida 166
Early research (Phase 1)Study completedNCT04194242
What this trial is testing

The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Sunshine Lake Pharma Co., Ltd. 64
Not applicableStudy completedNCT03786523
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Not applicableLooking for participantsNCT06124261
What this trial is testing

Androgens and NAFLD Longitudinal Cohort Study

Who this might be right for
PCOSNAFLDNASH
University of California, San Francisco 150
Not applicableLooking for participantsNCT07093346
What this trial is testing

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+7 more
University of Nottingham 45
Early research (Phase 1)Study completedNCT04146805
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects

Who this might be right for
Chronic Liver DiseaseNASH - Nonalcoholic Steatohepatitis
Blade Therapeutics 80
Not applicableStudy completedNCT04509245
What this trial is testing

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver, Nonalcoholic
German Diabetes Center 24
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Testing effectiveness (Phase 2)WithdrawnNCT05118360
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gannex Pharma Co., Ltd.
Very early researchStudy completedNCT06681597
What this trial is testing

Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans

Who this might be right for
ObesityDiabetesNAFLD (Nonalcoholic Fatty Liver Disease)
Nanchang University 60
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Testing effectiveness (Phase 2)Study completedNCT04080947
What this trial is testing

The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Steatohepatitis, Nonalcoholic
Sadat City University 56
Large-scale testing (Phase 3)UnknownNCT02530138
What this trial is testing

The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 42
Not applicableUnknownNCT05430178
What this trial is testing

Metabolic Pathology of Pediatric NAFLD

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisObesity
University of Oklahoma 100
Not applicableLooking for participantsNCT07237750
What this trial is testing

IWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Who this might be right for
Overweight and/or ObesityMetabolic SyndromeNonalcoholic Fatty Liver Disease+1 more
Liu Yan 216
Next Page